| # | Drug | Count |
|---|---|---|
| 0 | MEPOLIZUMAB | 31 |
| 1 | QUETIAPINE | 26 |
| 2 | CERTOLIZUMAB PEGOL | 21 |
| 3 | ALBUTEROL SULFATE | 19 |
| 4 | PREDNISONE | 14 |
| 5 | OLANZAPINE | 11 |
| 6 | PAROXETINE HYDROCHLORIDE | 10 |
| 7 | TOPIRAMATE | 10 |
| 8 | RITONAVIR | 9 |
| 9 | RITONAVIR 100 MG | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAMPHOR, CAPSAICIN, MENTHOL | 1 | 0.0019 |
| 1 | IMIPRAMINE HYDROCHLORIDE | 1 | 0.0018 |
| 2 | MENTHOL, UNSPECIFIED FORM | 1 | 0.0016 |
| 3 | AMISULPRIDE | 7 | 0.0011 |
| 4 | ZOLMITRIPTAN | 8 | 0.0011 |
| 5 | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | 1 | 0.0009 |
| 6 | LIDOCAINE AND PRILOCAINE | 1 | 0.0007 |
| 7 | MEPOLIZUMAB | 31 | 0.0006 |
| 8 | RITONAVIR 100 MG | 9 | 0.0006 |
| 9 | ETHOSUXIMIDE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 31 | 0.0451 |
| 1 | Dopamine-2 Receptor Antagonist [EPC] | 7 | 0.0009 |
| 2 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 8 | 0.0003 |
| 3 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 7 | 0.0002 |
| 4 | Protease Inhibitor [EPC] | 9 | 0.0002 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 9 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 7 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Atypical Antipsychotic [EPC] | 32 | 0.0001 |
| 9 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |